Indeed, if or when SMA is clinically determined/suspected and a heterozygous deletion is identified, sequencing of the whole coding region of the SMN1 gene is warranted to achieve the definitive diagnosis. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.